The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity

Abstract The size of nanoliposome‐encapsulated drugs significantly affects their therapeutic efficacy, biodistribution, targeting ability, and toxicity profile for the cancer treatment. In the present study, the biodistribution and anti‐tumoral activity of PEGylated liposomal Doxorubicin (PLD) formu...

Full description

Bibliographic Details
Main Authors: Saba Dadpour, Amin Mehrabian, Mahdieh Arabsalmani, Elaheh Mirhadi, Anis Askarizadeh, Mohammad Mashreghi, Mahmoud Reza Jaafari
Format: Article
Language:English
Published: Hindawi-IET 2022-09-01
Series:IET Nanobiotechnology
Subjects:
Biodistribution
Cancer
EPR effect
Nanoparticle size
PEGylated liposomal doxorubicin
Therapeutic efficacy
Online Access:https://doi.org/10.1049/nbt2.12094

Internet

https://doi.org/10.1049/nbt2.12094

Similar Items